Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederastrazeneca.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 104 followers
Latest posts
Last updated almost 2 years ago
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive, HER2-low or negative metastatic breast cancer
almost 2 years ago
Camizestrant significantly delayed disease progression in advanced ER-positive breast cancer, adding at least 3.5 months benefit versus Faslodex
almost 2 years ago
Capivasertib plus Faslodex reduced the risk of disease progression or death by 40% versus Faslodex in advanced HR-positive breast cancer
almost 2 years ago
AstraZeneca showcases strength of haematology portfolio and pipeline across multiple hard-to-treat conditions at ASH 2022
almost 2 years ago
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
almost 2 years ago
AstraZeneca aims to redefine breast cancer care with new data across the treatment spectrum at SABCS 2022
almost 2 years ago
Enhertu recommended for approval in the EU by CHMP for patients with previously treated HER2-positive advanced gastric cancer
about 2 years ago